Ozempic could delay ageing, researchers suggest

“Delayed aging” is not the right phrase. While, a eduction in all-cause mortality is good news this is not equivalent to delayed aging but is delayed risk and severity of diseases associated with aging. The individuals who were treated were not healthy older controls.

Low dose rapamycin (5 mg/week) to mildly inhibit mTORC1 networks would be far more effective as a true prolongevity treatment, even of healthy older adults. And given many studies of mice, dogs, yeast etc this drug at the right dose might actually slow aging rates.

https://pubmed.ncbi.nlm.nih.gov/37191826/